Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...
The decrease was primarily driven by lower consumer services revenue, mainly due to lower PGS kit sales volume and telehealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback